16 March 2018: Articles
Intraoperative Acute Respiratory Failure in an Immunocompromised Patient with Human Metapneumovirus
Unusual clinical course, Challenging differential diagnosis
Justin S. Merkow EF 1*, Erik J. Nelson EF 1DOI: 10.12659/AJCR.907604
Am J Case Rep 2018; 19:301-303
Abstract
BACKGROUND: Providing anesthesia to immunocompromised patients introduces unique challenges, including difficulty in detecting respiratory infections. Detailed preoperative evaluation and preparation for perioperative complications is crucial. Human metapneumovirus is a common but lesser known respiratory virus that can lead to pneumonia and respiratory compromise and is challenging to detect in the immunocompromised patient.
CASE REPORT: We present a case of an immunocompromised individual scheduled for umbilical hernia repair who developed severe bronchospasm and intraoperative respiratory failure after induction of general anesthesia. Preoperative evaluation of this patient revealed only minor respiratory symptoms and minimal rhonchi on lung auscultation. This patient did not meet extubation criteria in the operating room and was transferred to the medical intensive care unit. Human metapneumovirus was detected in his lower respiratory tract as the cause of the pneumonia and respiratory failure.
CONCLUSIONS: This case illustrates the difficulty in predicting pulmonary complications in immunocompromised patients and the potential severity of a respiratory infection with Human metapneumovirus. Detecting respiratory infections preoperatively in the immunocompromised patient is important for considering preoperative treatment or postponing elective surgery and potentially avoiding intraoperative respiratory failure.
Keywords: Intraoperative Care, Intraoperative Complications, Metapneumovirus, Respiratory System Abnormalities
Background
Pulmonary complications are important causes of perioperative morbidity. The incidence has been reported to be as high as 1% to 2% in even minor surgeries and upwards of 10% to 20% in upper abdominal or thoracic surgeries [1]. In addition, pneumonia is the most common invasive infection in immunocompromised patients and carries a high morbidity and mortality rate. Evaluation of immunocompromised patients can be difficult as signs and symptoms of infection can be subtle; missing a pulmonary infection during the perioperative period in this population can lead to devastating consequences.
Human metapneumovirus (hMPV) is a single negative-stranded RNA-enveloped virus in the
This case report is an illustration of how important it is to perform a thorough preoperative evaluation in immunocompromised patients and highlights the importance picking up on subtle signs of infection in this population. Our patient suffered from an intractable bronchospasm from just manipulating of the airway, illustrating the vulnerability of his respiratory status. Our case brings up the question of how much preoperative evaluation should be done in this sensitive population especially for minor elective surgeries.
Case Report
The patient was a 31-year-old male with end stage renal disease status post kidney transplant, immunosuppression, hypertension, obesity, and sleep apnea who presented for elective umbilical hernia repair. He had no history of pulmonary disease. His daily medications included myfortic, tacrolimus, and prednisone. His preoperative evaluation was unremarkable except for a minor cough and fatigue during the preceding week. The patient’s lungs were clear bilaterally and his vital signs were normal. Induction in the operating room was performed uneventfully with propofol, fentanyl, succinylcho-line, and ketamine. Shortly after induction, stress dose hydro-cortisone and rocuronium were given. He was maintained on 1 MAC of sevoflurane. Prior to surgical incision, the patient began coughing. His peak airway pressures increased to greater than 30 cm H2O and his saturation acutely decreased to less than 85%. He was immediately given 100% oxygen, additional neuromuscular blockade, and the sevoflurane concentration was increased while he was hand-ventilated. His lung compliance was very low, and he was difficult to ventilate. Albuterol was delivered, and an emergent bronchoscopy was undertaken which revealed diffuse erythema and copious white mucous throughout the airway bilaterally, which was suctioned. An arterial blood gas was sent and showed a Pa02 <80 mm Hg despite being on 100% oxygen. Following discussion with the surgeon, the decision was made to cancel surgery. The patient continued to be difficult to ventilate and oxygenate and therefore was transferred to the medical intensive care unit intubated. Chest x-ray upon arrival illustrated bilateral opacities, pulmonary congestion, and atelectasis (Figure 1). In the medical intensive care unit, a bronchoalveolar lavage was performed which revealed respiratory hMPV. The patient continued to have intermittent bronchospasms over the next 12 hours while being treated in the intensive care unit. The patient’s respiratory function normalized with resolution of the bronchospasm on hospital day 2 and he was extubated uneventfully. He fully recovered and was discharged to home on hospital day 3. The patient currently has decided not to have his umbilical hernia repaired.
Discussion
Immunocompromised patients can pose perioperative challenges, and in this case, it was an initial subclinical presentation of a respiratory viral infection. Data regarding perioperative evaluation and management of immunocompromised adult patients is not significantly divergent from our normal standard [4,5]. With just a cough and fatigue in the setting of a minor elective surgery, we felt that no further workup was indicated. Indeed, it would have been difficult to predict his respiratory infection preoperatively and his severe bronchospasm following induction of general anesthesia and airway manipulation.
Perioperative pulmonary complications occur in 6% of patients who undergo major abdominal surgery. Etiologies include infection, hypoxia, respiratory failure, bronchospasm, and obstructive disease exacerbation. It leads to increased hospital stay and a higher in hospital mortality rate [6,7]. Additionally, the estimated annual cost of perioperative pulmonary complications in the United States is 3.42 billion dollars. The ARISCAT study, a prospective multicenter study attempting to create a risk index for these complications, found that age >80 years, preoperative Sp02 <90%, preoperative hemoglobin <10 g/dL, upper abdominal or thoracic surgical incision, and surgery duration greater than 2 hours were all associated with increased pulmonary risk [8]. Other studies have also noted smoking, pulmonary hypertension, congestive heart failure, obstructive sleep apnea, and combined metabolic and nutritional factors to be important risk factors [8]. Although our patient did not have these factors, he was immunosuppressed, which put him at increased risk for infection.
Common viruses associated with respiratory tract infections include respiratory syncytial virus, parainfluenza, and adenovirus [9]. As stated previously, a less known, but common virus discovered in 2001 is hMPV [10]. It is a single stranded, negative sense, nonsegmented RNA virus that is a member of the
Conclusions
This case illustrates the difficulty in predicting pulmonary complications in immunocompromised patients and the potential severity of hMPV pulmonary infection in these individuals. Our patient with hMPV initially presented with severe bronchospasm and intraoperative respiratory failure. Intubation with airway manipulation was the instigating factor that made this first evident. Having a high index of suspicion for pulmonary infection, even with minor respiratory symptoms in this patient population is prudent. In retrospect, preoperative treatment or postponement of surgery may have avoided the severity of his pulmonary complications and may have allowed for a safe repair of his umbilical hernia.
References:
1.. Degani-Costa LH, Faresin SM, dos Reis Falcao LF, Preoperative evaluation of the patient with pulmonary disease: Braz J Anesthesiol, 2014; 64(1); 22-34, pmid: 24565385
2.. Falsey AR, Human metapneumovirus infection in adults: Pediatr Infect Dis J, 2008; 27(10 Suppl.); S80-83, pmid: 18820584
3.. Samuel S, Nanjappa S, Cooper CD, Greene JN, Human metapneumovirus infection in immunocompromised patients: Cancer Control, 2016; 23(4); 442-45, pmid: 27842334
4.. Littlewood KE, The immunocompromised adult patient and surgery: Best Pract Res Clin Anaesthesiol, 2008; 22(3); 585-609, pmid: 18831305
5.. Neskovic V, Preoperative assesment of the immunocompromised patient: Acta Chir Iugosl, 2011; 58(2); 185-92, pmid: 21879670
6.. Crowe JE, Human metapneumovirus as a major cause of human respiratory tract disease: Pediatr Infect Dis J, 2004; 23(11 Suppl.); S215-21, pmid: 15577576
7.. Smetana GW, Lawrence VA, Cornell JE, Preoperative pulmonary risk stratification for noncardiothoracic surgery:Ssystematic review for the American College of Physicians: Ann Intern Med, 2006; 144(8); 581-95, pmid: 16618956
8.. Canet J, Gallart L, Gomar C, Prediction of postoperative pulmonary complications in a population-based surgical cohort: Anesthesiology, 2010; 113(6); 1338-50, pmid: 21045639
9.. Jain S, Self WH, Wunderink RG, Community-acquired pneumonia requiring hospitalization among U.S. adults: N Engl J Med, 2015; 373(5); 415-27, pmid: 26172429
10.. Amer HM, Molecular epidemiology of human metapneumovirus in Riyadh Province, Saudi Arabia: J Mol Microbiol Biotechnol, 2016; 26(6); 414-21, pmid: 27694746
11.. Kroll JL, Weinberg A, Human metapneumovirus: Semin Respir Crit Care Med, 2011; 32(4); 447-53, pmid: 21858749
12.. Mazzoncini JP, Crowell CB, Kang CS, Human metapneumovirus: An emerging respiratory pathogen: J Emerg Med, 2010; 38(4); 456-59, pmid: 18584996
13.. Egli A, Bucher C, Dumoulin A, Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation: Infection, 2012; 40(6); 677-84, pmid: 22802096
14.. Debur MC, Vidal LR, Stroparo E, Human metapneumovirus infection in hematopoietic stem cell transplant recipients: Transpl Infect Dis, 2010; 12(2); 173-79, pmid: 19878491
15.. Falsey AR, Hennessey PA, Formica MA, Humoral immunity to human metapneumovirus infection in adults: Vaccine, 2010; 28(6); 1477-80, pmid: 20003919
16.. Maitre NL, Williams JV, Human metapneumovirus in the preterm neonate: Current perspectives: Res Rep Neonatol, 2016; 6; 41-49, pmid: 27891060
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






